Dynamics and control of a mathematical model for metronomic chemotherapy
From MaRDI portal
Publication:745131
DOI10.3934/mbe.2015.12.1257zbMath1326.92038OpenAlexW2409125697WikidataQ47579863 ScholiaQ47579863MaRDI QIDQ745131
Behrooz Amini, Urszula Łedzewicz-Kowalewska, Heinz Schättler
Publication date: 13 October 2015
Published in: Mathematical Biosciences and Engineering (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/mbe.2015.12.1257
optimal controlmetronomic chemotherapycancer treatmentangiogenic signalingtumor immune-system interactions
Related Items (5)
Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases ⋮ On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach ⋮ Optimizing the delivery of combination therapy for tumors: A mathematical model ⋮ Chemoimmunotherapy for the treatment of prostate cancer: insights from mathematical modelling ⋮ Resilience analysis for competing populations
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Mathematical modeling of glioma therapy using oncolytic viruses
- On optimal chemotherapy with a strongly targeted agent for a model of tumor-immune system interactions with generalized logistic growth
- Geometric optimal control. Theory, methods and examples
- Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics
- Interaction of tumor with its micro-environment: a mathematical model
- Critical-point analysis for three-variable cancer angiogenesis models
- Role of optimal control theory in cancer chemotherapy
- Nonlinear oscillations, dynamical systems, and bifurcations of vector fields
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers
- Singular trajectories and their role in control theory
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
- Cancer chemotherapy optimization under evolving drug resistance.
- Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis
- Drug resistance in cancer chemotherapy as an optimal control problem
- A Review of Optimal Chemotherapy Protocols: From MTD towards Metronomic Therapy
- Modeling the Impact of Anticancer Agents on Metastatic Spreading
- ON OPTIMAL CHEMOTHERAPY FOR HETEROGENEOUS TUMORS
- MODELING AND OPTIMAL CONTROL FOR ANTIRETROVIRAL THERAPY
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY
- ANTI-TUMOR IMMUNITY AND TUMOR ANTI-IMMUNITY IN A MATHEMATICAL MODEL OF TUMOR IMMUNOTHERAPY
- Dynamic response of cancer under the influence of immunological activity and therapy
This page was built for publication: Dynamics and control of a mathematical model for metronomic chemotherapy
